STAT - Reporting from the frontiers of health and medicine

Health

By Kathleen McLaughlin

Biotech

First Opinion

By Lauren Hines

First Opinion Rethinking Black Friday to include end-of-life conversations
Pharmalot House committee wants Purdue CEO and Sackler family members to testify at opioid crisis hearing
Health Study offers new clues for treating brain cancer in children
First Opinion Add Covid-related myocarditis, mechanical ventilation, and death to this year’s football risks
Politics Which pricey drugs will Trump’s international pricing policy target?

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

Alnylam wins FDA approval for first drug to treat rare kidney disease
How Amazon Pharmacy could ramp up pressure on the prescription drug industry
Pharmalittle: Purdue pleads guilty to opioid charges; Chinese firm files for Covid-19 vaccine approval

Health

Don't Miss

By STAT staff

Health Tech

By Juliet Isselbacher

Special Report

Health

By Gabrielle Glaser

Health

By Amy Sokolow

Special Report The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine race
First Opinion I worked hard to protect myself from Covid-19 and the flu. Yet I got both — at the same time
Health Mask defiance remains strong in Big Sky Country, even as the pandemic rages
Health The Covid-19 Tracker
Health Amid pandemic, U.S. has seen 300,000 ‘excess deaths,’ with highest rates among people of color
Special Report Data show hospitalized Covid-19 patients are surviving at higher rates, but surge in cases could roll back gains
Special Report The Road Ahead: Charting the coronavirus pandemic over the next 12 months — and beyond
First Opinion 23andMe had devastating news about my health. I wish a person had delivered it